🌀 Pediatric Migraine, GI Comorbidity & Gut–Brain Targeting: Bifidobacterium longum’s Clinical Role

🔥 Main in 3 points

• Pediatric migraine with GI disorders shows distinct gut microbiota: reduced B. longum, increased Bacteroides, and elevated fecal calprotectin.
• Supplementation with B. longum reduced headache days, frequency, intensity in an exploratory pediatric pilot.
• Preclinical models support B. longum’s neuromodulatory and anti-inflammatory effect along the gut–brain axis.

🧪 Context

Prospective cohort (n=126 pediatric migraine patients; 50 controls), with Rome IV GI stratification. Microbiome, headache assessments, markers (PedMIDAS, calprotectin, CGRP), and pilot supplementation study (n=23). Parallel rat models confirmed mechanistic benefit.

📍 Practical significance

Children/adolescents with migraine and GI symptoms may particularly benefit from B. longum-based strategies. Consider a trial of supplementation in patients with disabling migraine and GI comorbidity. Symptom improvement noted in both headache and GI domains. Supports a gut–brain axis intervention even before definitive RCT evidence in pediatric clinical care.

🔗 PubMed | DOI:10.1080/19490976.2025.2606487

❓ Practice Question: Can Bifidobacterium longum enhance executive function in children with neurodevelopmental disorders?

✅ Study answer

Probiotic supplementation (combo: B. longum, L. acidophilus, B. lactis) over two months improved executive function scores in children with ADHD compared to placebo (mean score drop from ~191 to ~151 in active, no significant change in placebo; F=7.93, p<0.001).

📍 How to apply

Consider a two-month adjunctive probiotic (including B. longum) for children with ADHD targeting cognitive/executive function, especially where medication options cause side effects. Monitor improvement via parent-reported tools; optimal responders may have more pronounced gut–brain involvement.

🔗 PubMed | DOI:10.1002/npr2.70084

🧾 New Gut–Brain Signals in IBS/FGID Overlap – No 35624/Alflorex-specific papers in this batch.

✅ Do

• Recognize reduced B. longum as a reproducible finding in pediatric migraine (with/without GI comorbidity); restoration linked to clinical benefit.
• Consider B. longum–inclusive probiotics for neurodevelopmental cases with GI overlap.

⚠️ With caution

• Pediatric/gut–brain disorder evidence expanding, but mature RCT data in IBS for specific B. longum strains (including 35624) remain needed for clear guidance.

🚫 Avoid

• Assuming microbiome shifts or symptom improvement are generalizable to adult DGBI/IBS without phenotype-specific studies.

🔗 PubMed: 41454664 | PubMed: 41450035

🌀 Bifidobacterium longum and the Gut–Lung Axis: Early Childhood Asthma Signal

🧠 Key results

• B. longum is associated with improved lung function (FEV1/FVC) in children post-bronchiolitis, per metagenomic profiling.
• Host genetics modulate these effects: stronger association in those with higher polygenic risk scores for lung function.
• No specific intervention/trial; observational signal but relevant for early-life microbiome shaping.

📍 What this changes in practice

Integrating microbiome support (diet, perhaps B. longum-containing probiotics) in high-risk children post-bronchiolitis may have respiratory benefit potential. Genotype may influence response.

🔗 PubMed | DOI:10.1016/j.jaci.2025.12.1005